- Ipsen is the first pharma company in the world to receive Shingo Prizes for two sites producing treatments for patients
- Ipsen's first Shingo Prize was received by its production site in Signes, France in 2020, followed by the site in Dublin, Ireland today
- The Shingo Prize represents the highest standard of operational excellence in the world
PARIS, FRANCE, 14 October 2024 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that its Dublin, Ireland production site has received the Shingo Prize for operational excellence. This is Ipsen's second Shingo Prize, with its site in Signes, France, receiving the first award in 2020.
Created in 1988, the Shingo Prize recognizes companies across all sectors that demonstrate a strong culture of operational excellence, deeply rooted in the mindset and behaviors of all staff, management and employees alike. This prestigious award is given to a maximum of five companies each year.